ACIES BIO
Desconocido
BeXyl: Beyond Xylella Integrated Management Strategies for Mitigating Xylella fastidiosa impact in Europe...
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
participó en un
HORIZON EUROPE:
HORIZON-CL6-2021-FARM2FORK-01
BeXyl will contribute to promote research and innovation and specifically provide interdisciplinary solutions according to the demand of the...
2022-07-20 - 2026-08-31 | Financiado
2022-07-20 - 2026-08-31 | Financiado
BIOVEXO: Biocontrol of Xylella and its vector in olive trees for integrated pest management
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
participó en un
H2020:
H2020-BBI-JTI-2019
BIOVEXO demonstrates a set of new and innovative biopesticides targeting the plant-pathogenic Xylella bacterium and its transmitting spittle...
2020-03-27 - 2025-04-30 | Financiado
2020-03-27 - 2025-04-30 | Financiado
SUSFERT: Sustainable multifunctional fertilizer combining bio coatings probiotics and struvite for phospho...
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
participó en un
H2020:
H2020-BBI-JTI-2017
SUSFERT addresses the massive usage of mineral fertilisers in EU agriculture, which are largely based on non-renewable resources, but are re...
2018-04-26 - 2023-12-31 | Financiado
2018-04-26 - 2023-12-31 | Financiado
M-DrivE: Metabolic Drivers of Epigenetic Modifications metabolic inducers of histone post translational modi...
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
tramitó un
H2020:
H2020-MSCA-IF-2016
Post-translational chemical modifications to histone proteins – the storage units of DNA – influence gene expression electrostatically and t...
2017-04-04 - 2020-04-30 | Financiado
2017-04-04 - 2020-04-30 | Financiado
CoALIVE: Coenzyme A Launch of In Vivo Experiments
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
tramitó un
H2020:
H2020-INNOSUP-2016-2017
Acies Bio is looking to hire an expert on disease model development – particularly whole organism models in fruit flies – to join our drug d...
2017-02-27 - 2018-09-28 | Financiado
2017-02-27 - 2018-09-28 | Financiado
TOPCAPI: Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
participó en un
H2020:
H2020-NMBP-2016-2017
TOPCAPI will exploit the natural fabrication power of actinomycetes as microbial cell factories to produce three high value compounds: GE227...
2016-11-09 - 2021-09-30 | Financiado
2016-11-09 - 2021-09-30 | Financiado
WHEY2VALUE: Whey2Value Valorising waste whey into high value products
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
tramitó un
H2020:
H2020-SMEInst-2014-2015
ACIES BIO, a SME with a decade of profound experience and market understanding, has developed an innovative and disruptive technology alread...
2015-10-15 - 2017-10-31 | Financiado
2015-10-15 - 2017-10-31 | Financiado
WHEY2VALUE: Whey2Value valorising waste whey into high value products
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
tramitó un
H2020:
H2020-SMEInst-2014-2015
ACIES BIO has developed an innovative and disruptive high-value technology to address a major economical and environmental challenge of the...
2015-01-21 - 2015-05-31 | Financiado
2015-01-21 - 2015-05-31 | Financiado
TIRCON: Treat Iron Related Childhood Onset Neurodegeneration
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO
participó en un
FP7:
Neurodegeneration with brain iron accumulation (NBIA) is a heterogeneous group of rare hereditary neurodegenerative disorders characterized...
Financiado
Financiado
* No se disponen de datos de la empresa actual.